Display options
Cite
Mauri MC, Paletta S, Maffini M, et al. Clinical pharmacology of atypical antipsychotics: an update. EXCLI J. 2014;13:1163-91
Mauri, M. C., Paletta, S., Maffini, M., Colasanti, A., Dragogna, F., Di Pace, C., & Altamura, A. C. (2014). Clinical pharmacology of atypical antipsychotics: an update. EXCLI journal, 131163-91.
Mauri, M C, et al. "Clinical pharmacology of atypical antipsychotics: an update." EXCLI journal vol. 13 (2014): 1163-91.
Mauri MC, Paletta S, Maffini M, Colasanti A, Dragogna F, Di Pace C, Altamura AC. Clinical pharmacology of atypical antipsychotics: an update. EXCLI J. 2014 Oct 13;13:1163-91. eCollection 2014. PMID: 26417330; PMCID: PMC4464358.
Copy Download .nbib Format: NLM
Share it on

EXCLI J. 2014 Oct 13;13:1163-91. eCollection 2014.

Clinical pharmacology of atypical antipsychotics: an update.

EXCLI journal

M C Mauri, S Paletta, M Maffini, A Colasanti, F Dragogna, C Di Pace, A C Altamura

Affiliations

  1. Department of Neuroscience and Mental Health, Pychiatric Unit, Clinical Neuropsychopharmacology Unit, University of Milan, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122 Milano, Italy.
  2. Center for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, King's College Denmark Hill, London SE5 8AF, England.

PMID: 26417330 PMCID: PMC4464358

Abstract

This review will concentrate on the clinical pharmacology, in particular pharmacodynamic data, related to atypical antipsychotics, clozapine, risperidone, paliperidone, olanzapine, que¬tiapine, amisulpride, ziprasidone, aripiprazole, asenapine, iloperidone, lurasidone and cariprazine. A summary of their acute pharmacokinetics properties are also reported. Four new second-generation antipsychotics are available: iloperidone, asenapine, lurasidone and in the next future cariprazine. Similar to ziprasidone and aripiprazole, these new agents are advisable for the lower propensity to give weight gain and metabolic abnormalities in comparison with older second-generation antipsychotics such as olanzapine or clozapine. Actually lurasidone seems to be best in terms of minimizing unwanted alterations in body weight and metabolic variables. Therapeutic drug monitoring is not strictly necessary for all of the new antipsychotic drugs because there are no unequivocal data supporting a relationship between plasma drug levels and clinical outcomes or side effects. The exception can be represented by clozapine for which plasma levels of 350-420 ng/ml are reported to be associated with an increased probability of a good clinical response. Also for olanzapine an established therapeutic range (20-50 ng/ml) is proposed to yield an optimal response and minimize side effects.

References

  1. Ther Drug Monit. 1999 Feb;21(1):87-90 - PubMed
  2. Neuropsychopharmacology. 1999 May;20(5):491-505 - PubMed
  3. Br J Psychiatry Suppl. 1999;(37):36-40 - PubMed
  4. Neuropsychopharmacology. 1999 Jun;20(6):612-27 - PubMed
  5. Clin Pharmacokinet. 1999 Sep;37(3):177-93 - PubMed
  6. Schizophr Res. 1999 Nov 30;40(2):101-4 - PubMed
  7. Schizophr Bull. 1999;25(4):721-9 - PubMed
  8. Br J Clin Pharmacol. 2000;49 Suppl 1:5S-13S - PubMed
  9. Br J Clin Pharmacol. 2000;49 Suppl 1:15S-20S - PubMed
  10. Br J Clin Pharmacol. 2000;49 Suppl 1:35S-42S - PubMed
  11. Arch Gen Psychiatry. 2000 Jun;57(6):553-9 - PubMed
  12. Eur Psychiatry. 2000 Aug;15(5):321-9 - PubMed
  13. Psychopharmacology (Berl). 2001 Jan 1;153(2):238-43 - PubMed
  14. Eur Psychiatry. 2001 Feb;16(1):57-63 - PubMed
  15. Eur Neuropsychopharmacol. 2001 Apr;11(2):105-10 - PubMed
  16. Schizophr Res. 2001 May 30;50(1-2):89-93 - PubMed
  17. Clin Pharmacokinet. 2001;40(7):509-22 - PubMed
  18. Eur J Pharmacol. 2001 Aug 17;425(3):197-201 - PubMed
  19. Clin Ther. 2002 Jan;24(1):21-37 - PubMed
  20. Can J Psychiatry. 2002 Feb;47(1):27-38 - PubMed
  21. CNS Drugs. 2002;16(4):249-61 - PubMed
  22. Ann Pharmacother. 2002 May;36(5):839-51 - PubMed
  23. Arch Gen Psychiatry. 2002 May;59(5):441-8 - PubMed
  24. Eur J Pharmacol. 2002 Apr 26;441(3):137-40 - PubMed
  25. J Pharmacol Exp Ther. 2002 Jul;302(1):381-9 - PubMed
  26. Neuropsychopharmacology. 2002 Aug;27(2):248-59 - PubMed
  27. CNS Drugs. 2002;16(9):645-52 - PubMed
  28. J Clin Psychopharmacol. 2002 Oct;22(5):530-2 - PubMed
  29. CNS Drugs. 2002;16(11):779-86; discussion 787-8 - PubMed
  30. Hum Psychopharmacol. 2002 Jan;17(1):1-13 - PubMed
  31. Neuropsychopharmacology. 2002 Dec;27(6):1050-5 - PubMed
  32. Ther Drug Monit. 2003 Feb;25(1):46-53 - PubMed
  33. Biol Psychiatry. 2003 Feb 1;53(3):193-203 - PubMed
  34. J Clin Psychopharmacol. 2003 Jun;23(3):229-32 - PubMed
  35. Clin Pharmacokinet. 2003;42(7):607-18 - PubMed
  36. Psychiatry Res. 2003 Jul 15;119(1-2):113-23 - PubMed
  37. Am J Psychiatry. 2003 Aug;160(8):1396-404 - PubMed
  38. Ther Drug Monit. 2003 Dec;25(6):657-64 - PubMed
  39. Ther Drug Monit. 2003 Dec;25(6):682-9 - PubMed
  40. Am J Health Syst Pharm. 2003 Dec 1;60(23):2437-45 - PubMed
  41. Can J Psychiatry. 2003 Dec;48(11):716-21 - PubMed
  42. Neurosci Lett. 2004 Feb 12;356(2):135-9 - PubMed
  43. J Clin Pharmacol. 2004 Feb;44(2):179-87 - PubMed
  44. Psychiatry Clin Neurosci. 2004 Apr;58(2):168-72 - PubMed
  45. Eur Neuropsychopharmacol. 2004 May;14(3):245-50 - PubMed
  46. Schizophr Res. 2004 Feb 1;66(2-3):197-8 - PubMed
  47. Am J Psychiatry. 2004 May;161(5):818-25 - PubMed
  48. J Clin Psychopharmacol. 2004 Apr;24(2):214-9 - PubMed
  49. Clin Ther. 2004 May;26(5):649-66 - PubMed
  50. Schizophr Res. 2004 Sep 1;70(1):91-100 - PubMed
  51. Drugs. 2004;64(15):1715-36 - PubMed
  52. Mol Psychiatry. 2005 Jan;10(1):79-104 - PubMed
  53. CNS Spectr. 2004 Oct;9(10 Suppl 11):6-14 - PubMed
  54. Drugs. 2004;64(23):2709-26 - PubMed
  55. Pharmacopsychiatry. 2004 Nov;37(6):243-65 - PubMed
  56. Eur Arch Psychiatry Clin Neurosci. 2005 Aug;255(4):261-8 - PubMed
  57. J Clin Pharmacol. 2005 Jan;45(1):89-93 - PubMed
  58. Eur Psychiatry. 2005 Jan;20(1):55-60 - PubMed
  59. Ther Drug Monit. 2005 Feb;27(1):103-6 - PubMed
  60. Acta Psychiatr Scand. 2005 Mar;111(3):232-43 - PubMed
  61. Int J Neuropsychopharmacol. 2005 Mar;8(1):27-36 - PubMed
  62. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD001359 - PubMed
  63. J Clin Pharmacol. 2005 Jun;45(6):620-30 - PubMed
  64. J Psychiatr Pract. 2005 Sep;11(5):289-301 - PubMed
  65. Int J Neurosci. 2005 Nov;115(11):1539-47 - PubMed
  66. Clin Pharmacokinet. 2005;44(11):1117-33 - PubMed
  67. Br J Clin Pharmacol. 2006 Jan;61(1):58-69 - PubMed
  68. Encephale. 2005 Sep-Oct;31(5 Pt 1):609-15 - PubMed
  69. CNS Drugs. 2006;20(5):389-409 - PubMed
  70. Am J Psychiatry. 1991 Feb;148(2):231-5 - PubMed
  71. Acta Psychiatr Scand. 2006 Jul;114(1):21-6 - PubMed
  72. Eur Neuropsychopharmacol. 2007 Jan 15;17(2):102-7 - PubMed
  73. Curr Med Res Opin. 2006 Oct;22(10):1879-92 - PubMed
  74. Int Clin Psychopharmacol. 2007 Jan;22(1):21-7 - PubMed
  75. Clin Pharmacokinet. 2007;46(5):359-88 - PubMed
  76. Pharmacopsychiatry. 2007 May;40(3):89-92 - PubMed
  77. Am J Psychiatry. 2007 Sep;164(9):1411-7 - PubMed
  78. Neuroscience. 2007 Oct 12;149(1):192-202 - PubMed
  79. Expert Opin Pharmacother. 2007 Oct;8(14):2207-13 - PubMed
  80. J Clin Psychiatry. 2008 Jan;69(1):81-6 - PubMed
  81. CNS Spectr. 2008 May;13(5 Suppl 9):1-16 - PubMed
  82. CNS Drugs. 2008;22(10):807-13 - PubMed
  83. Clin Ther. 2010;32 Suppl 1:S3-20 - PubMed
  84. Neuropsychiatr Dis Treat. 2010 Jun 24;6:261-7 - PubMed
  85. Mol Psychiatry. 2011 Sep;16(9):960-72 - PubMed
  86. Neuropsychiatr Dis Treat. 2010 Sep 07;6:573-81 - PubMed
  87. Clin Drug Investig. 2010;30(12):827-841 - PubMed
  88. Drugs. 2010 Dec 3;70(17):2289-313 - PubMed
  89. CNS Neurosci Ther. 2011 Feb;17(1):58-65 - PubMed
  90. Schizophr Res. 2011 Apr;127(1-3):188-94 - PubMed
  91. Am J Health Syst Pharm. 2011 Feb 15;68(4):301-8 - PubMed
  92. Psychopharmacology (Berl). 2011 Dec;218(3):579-87 - PubMed
  93. Clin Pharmacokinet. 2011 Jul;50(7):471-81 - PubMed
  94. Neurochem Int. 2011 Nov;59(6):925-35 - PubMed
  95. Pharm Res. 1990 Apr;7(4):347-51 - PubMed
  96. Rev Recent Clin Trials. 2012 Feb;7(1):2-9 - PubMed
  97. Clin Drug Investig. 2012 Mar 1;32(3):213-9 - PubMed
  98. Neuropsychiatr Dis Treat. 2012;8:155-68 - PubMed
  99. Expert Opin Drug Metab Toxicol. 2012 Jul;8(7):873-88 - PubMed
  100. Adv Ther. 2012 Oct;29(10):815-25 - PubMed
  101. Expert Rev Clin Pharmacol. 2013 Jan;6(1):61-91 - PubMed
  102. J Clin Psychiatry. 2012 Dec;73(12):1533-40 - PubMed
  103. CNS Spectr. 2013 Feb;18(1):43-54 - PubMed
  104. Expert Opin Drug Metab Toxicol. 2013 Feb;9(2):193-206 - PubMed
  105. Adv Ther. 2013 Feb;30(2):114-26 - PubMed
  106. J Clin Psychiatry. 2013 May;74(5):507-15 - PubMed
  107. Curr Med Res Opin. 2013 Jul;29(7):813-25 - PubMed
  108. Ther Clin Risk Manag. 2013;9:319-28 - PubMed
  109. CNS Drugs. 2013 Nov;27(11):879-911 - PubMed
  110. Behav Brain Res. 2014 Mar 15;261:26-30 - PubMed
  111. Cochrane Database Syst Rev. 2013 Dec 17;(12):CD005000 - PubMed
  112. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:94-101 - PubMed
  113. Neuropsychiatr Dis Treat. 2014 Feb 26;10:409-15 - PubMed
  114. J Pharmacol Exp Ther. 1988 Nov;247(2):661-70 - PubMed
  115. J Affect Disord. 2014 Jun;162:20-5 - PubMed
  116. Expert Opin Drug Metab Toxicol. 2014 Jun;10(6):893-903 - PubMed
  117. Eur Arch Psychiatry Neurol Sci. 1989;238(5-6):332-9 - PubMed
  118. CNS Drugs. 1998 Apr;9(4):325-40 - PubMed
  119. J Neurosci. 1983 Aug;3(8):1607-19 - PubMed
  120. Can J Psychiatry. 1993 Sep;38 Suppl 3:S80-8 - PubMed
  121. Drug Metab Dispos. 1993 Nov-Dec;21(6):1134-41 - PubMed
  122. Am J Psychiatry. 1994 Jun;151(6):825-35 - PubMed
  123. Drugs. 1994 Aug;48(2):253-73 - PubMed
  124. Br J Psychiatry. 1995 Jun;166(6):712-26; discussion 727-33 - PubMed
  125. Am J Psychiatry. 1995 Oct;152(10):1444-9 - PubMed
  126. Clin Ther. 1995 May-Jun;17(3):366-78 - PubMed
  127. Am J Psychiatry. 1995 Feb;152(2):179-82 - PubMed
  128. J Clin Psychiatry. 1994 Sep;55 Suppl B:133-6 - PubMed
  129. Clin Pharmacokinet. 1993 Feb;24(2):161-76 - PubMed
  130. Eur J Pharmacol. 1995 Oct 15;291(2):59-66 - PubMed
  131. Drug Saf. 1996 May;14(5):288-98 - PubMed
  132. Neuropsychopharmacology. 1996 Feb;14(2):97-105 - PubMed
  133. J Pharmacol Exp Ther. 1997 Jan;280(1):73-82 - PubMed
  134. Drug Metab Dispos. 1997 Jan;25(1):81-93 - PubMed
  135. Clin Pharmacokinet. 1997 Feb;32(2):93-100 - PubMed
  136. Arch Gen Psychiatry. 1997 Jun;54(6):549-57 - PubMed
  137. Biol Psychiatry. 1997 Aug 15;42(4):233-46 - PubMed
  138. Acta Psychiatr Scand. 1997 Oct;96(4):265-73 - PubMed
  139. J Clin Psychopharmacol. 1997 Dec;17(6):472-7 - PubMed
  140. J Clin Psychopharmacol. 1997 Dec;17(6):478-84 - PubMed
  141. Psychopharmacology (Berl). 1998 Jan;135(2):119-26 - PubMed
  142. Pharmacopsychiatry. 1998 May;31(3):102-9 - PubMed
  143. Am J Psychiatry. 1998 Jul;155(7):921-8 - PubMed

Publication Types